Met Life Investment Management, LLC Glaukos Corp Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 29,561 shares of GKOS stock, worth $3.06 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,561
Previous 27,902 5.95%
Holding current value
$3.06 Million
Previous $3.64 Million 21.93%
% of portfolio
0.02%
Previous 0.02%

Shares

51 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$126.42 - $152.67 $209,730 - $253,279
1,659 Added 5.95%
29,561 $4.43 Million
Q3 2024

Nov 13, 2024
SELL
$113.62 - $135.39 $37,721 - $44,949
-332 Reduced 1.18%
27,902 $3.64 Million
Q2 2024

Aug 13, 2024
BUY
$89.48 - $118.35 $349,777 - $462,630
3,909 Added 16.07%
28,234 $3.34 Million
Q1 2024

May 14, 2024
BUY
$76.4 - $96.33 $1.86 Million - $2.34 Million
24,325 New
24,325 $2.29 Million
Q4 2023

Feb 14, 2024
BUY
$59.53 - $85.11 $11,072 - $15,830
186 Added 0.76%
24,769 $1.97 Million
Q3 2023

May 09, 2024
BUY
$69.23 - $79.09 $29,215 - $33,375
422 Added 1.75%
24,583 $1.85 Million
Q2 2023

Apr 29, 2024
BUY
$45.44 - $71.21 $1.12 Million - $1.75 Million
24,583 New
24,583 $1.75 Million
Q2 2023

Aug 10, 2023
BUY
$45.44 - $71.21 $19,175 - $30,050
422 Added 1.75%
24,583 $1.75 Million
Q1 2023

May 09, 2024
BUY
$43.88 - $52.48 $1.06 Million - $1.27 Million
24,161 New
24,161 $1.21 Billion
Q4 2022

May 10, 2024
SELL
$40.82 - $57.75 $36,574 - $51,744
-896 Reduced 3.58%
24,161 $1.06 Million
Q4 2022

Mar 22, 2023
SELL
$40.82 - $57.75 $36,574 - $51,744
-896 Reduced 3.58%
24,161 $1.06 Million
Q4 2022

Feb 15, 2023
SELL
$40.82 - $57.75 $36,574 - $51,744
-896 Reduced 3.58%
24,161 $1.06 Million
Q3 2022

Jun 14, 2023
BUY
$46.84 - $58.49 $41,968 - $52,407
896 Added 3.71%
25,057 $1.33 Million
Q2 2022

Jun 20, 2023
BUY
$34.86 - $63.77 $31,234 - $57,137
896 Added 3.71%
25,057 $1.14 Million
Q1 2022

May 10, 2024
BUY
$44.33 - $57.82 $1.11 Million - $1.45 Million
25,057 New
25,057 $1.45 Million
Q1 2022

Jun 20, 2023
BUY
$44.33 - $57.82 $39,719 - $51,806
896 Added 3.71%
25,057 $1.45 Million
Q1 2022

Mar 22, 2023
BUY
$44.33 - $57.82 $393,029 - $512,632
8,866 Added 54.76%
25,057 $1.45 Million
Q1 2022

May 12, 2022
BUY
$44.33 - $57.82 $393,029 - $512,632
8,866 Added 54.76%
25,057 $1.45 Million
Q4 2021

Jun 21, 2023
SELL
$40.27 - $56.99 $320,951 - $454,210
-7,970 Reduced 32.99%
16,191 $719,000
Q3 2021

Jun 21, 2023
SELL
$47.43 - $84.23 $378,017 - $671,313
-7,970 Reduced 32.99%
16,191 $779,000
Q2 2021

Jun 21, 2023
SELL
$73.06 - $97.7 $582,288 - $778,669
-7,970 Reduced 32.99%
16,191 $1.37 Million
Q1 2021

May 17, 2024
SELL
$70.43 - $97.42 $572,877 - $792,414
-8,134 Reduced 33.44%
16,191 $1.36 Million
Q1 2021

Jun 26, 2023
SELL
$70.43 - $97.42 $561,327 - $776,437
-7,970 Reduced 32.99%
16,191 $1.36 Billion
Q1 2021

Mar 22, 2023
SELL
$70.43 - $97.42 $86,065 - $119,047
-1,222 Reduced 7.02%
16,191 $1.36 Million
Q1 2021

May 14, 2021
SELL
$70.43 - $97.42 $86,065 - $119,047
-1,222 Reduced 7.02%
16,191 $1.36 Million
Q4 2020

May 24, 2024
SELL
$48.9 - $75.26 $73,007 - $112,363
-1,493 Reduced 7.9%
17,413 $1.31 Million
Q4 2020

Jun 22, 2023
SELL
$48.9 - $75.26 $329,977 - $507,854
-6,748 Reduced 27.93%
17,413 $1.31 Million
Q4 2020

Mar 22, 2023
SELL
$48.9 - $75.26 $73,007 - $112,363
-1,493 Reduced 7.9%
17,413 $1.31 Million
Q4 2020

Feb 16, 2021
SELL
$48.9 - $75.26 $73,007 - $112,363
-1,493 Reduced 7.9%
17,413 $1.31 Million
Q3 2020

Jun 26, 2023
SELL
$37.23 - $50.97 $195,643 - $267,847
-5,255 Reduced 21.75%
18,906 $936,000
Q2 2020

May 24, 2024
SELL
$28.78 - $46.83 $155,958 - $253,771
-5,419 Reduced 22.28%
18,906 $726 Million
Q2 2020

Jun 26, 2023
SELL
$28.78 - $46.83 $151,238 - $246,091
-5,255 Reduced 21.75%
18,906 $726,000
Q2 2020

Mar 22, 2023
BUY
$28.78 - $46.83 $63,200 - $102,838
2,196 Added 13.14%
18,906 $726,000
Q2 2020

Aug 14, 2020
BUY
$28.78 - $46.83 $63,200 - $102,838
2,196 Added 13.14%
18,906 $726,000
Q1 2020

Jul 12, 2023
SELL
$25.53 - $70.14 $190,224 - $522,613
-7,451 Reduced 30.84%
16,710 $515,000
Q4 2019

Jul 12, 2023
SELL
$54.18 - $65.64 $403,695 - $489,083
-7,451 Reduced 30.84%
16,710 $910,000
Q4 2019

Mar 22, 2023
BUY
$54.18 - $65.64 $66,370 - $80,409
1,225 Added 7.91%
16,710 $910,000
Q4 2019

Feb 14, 2020
BUY
$54.18 - $65.64 $66,370 - $80,409
1,225 Added 7.91%
16,710 $910,000
Q3 2019

Jul 12, 2023
SELL
$58.58 - $83.91 $508,240 - $728,003
-8,676 Reduced 35.91%
15,485 $967,000
Q3 2019

Mar 22, 2023
BUY
$58.58 - $83.91 $2,284 - $3,272
39 Added 0.25%
15,485 $967,000
Q3 2019

Nov 14, 2019
BUY
$58.58 - $83.91 $2,284 - $3,272
39 Added 0.25%
15,485 $968,000
Q2 2019

Jul 12, 2023
SELL
$63.59 - $78.71 $473,936 - $586,625
-7,453 Reduced 30.85%
16,708 $1.26 Million
Q1 2019

Jul 13, 2023
SELL
$50.75 - $80.54 $442,286 - $701,906
-8,715 Reduced 36.07%
15,446 $1.21 Million
Q4 2018

Jul 13, 2023
SELL
$52.18 - $67.93 $454,748 - $592,009
-8,715 Reduced 36.07%
15,446 $867,000
Q4 2018

Mar 22, 2023
SELL
$52.18 - $67.93 $444,521 - $578,695
-8,519 Reduced 35.55%
15,446 $867,000
Q4 2018

Feb 14, 2019
SELL
$52.18 - $67.93 $444,521 - $578,695
-8,519 Reduced 35.55%
15,446 $868,000
Q3 2018

Jul 13, 2023
SELL
$38.13 - $68.37 $332,302 - $595,844
-8,715 Reduced 36.07%
15,446 $1 Million
Q3 2018

Mar 22, 2023
SELL
$38.13 - $68.37 $7,473 - $13,400
-196 Reduced 0.81%
23,965 $1.56 Million
Q3 2018

Nov 14, 2018
BUY
$38.13 - $68.37 $324,829 - $582,444
8,519 Added 55.15%
23,965 $1.56 Million
Q2 2018

Aug 15, 2018
BUY
$27.62 - $44.51 $50,765 - $81,809
1,838 Added 13.51%
15,446 $628,000
Q4 2017

Feb 15, 2018
BUY
$24.5 - $36.01 $333,396 - $490,024
13,608
13,608 $349,000

Others Institutions Holding GKOS

# of Institutions
354
Shares Held
47.9M
Call Options Held
282K
Put Options Held
401K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.93B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email